CTXR (Citius Pharmaceuticals Inc. Common) Stock Analysis - SEC Filings

Citius Pharmaceuticals Inc. Common (CTXR) is a publicly traded Healthcare sector company. As of May 21, 2026, CTXR trades at $0.56 with a market cap of $14.47M and a P/E ratio of -0.26. CTXR moved +4.31% today. Year to date, CTXR is -38.29%; over the trailing twelve months it is -21.47%. Its 52-week range spans $0.48 to $13.52. Rallies surfaces CTXR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find CTXR SEC filings?

Rallies organizes CTXR SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

CTXR Key Metrics

Key financial metrics for CTXR
MetricValue
Price$0.56
Market Cap$14.47M
P/E Ratio-0.26
EPS$-2.24
Dividend Yield0.00%
52-Week High$13.52
52-Week Low$0.48
Volume5.37K
Avg Volume0
Revenue (TTM)$5.61M
Net Income$-55.45M
Gross Margin0.00%

Latest CTXR News

CTXR Analyst Consensus

CTXR analyst coverage data. Average price target: $0.00.

Common questions about CTXR

Where can I find CTXR SEC filings?
Rallies organizes CTXR SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show CTXR 10-K and 10-Q filings?
Rallies organizes CTXR SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is CTXR research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CTXR. It does not provide personalized investment advice.
CTXR

CTXR